Original language | English |
---|---|
Journal | Journal of clinical oncology |
Volume | 35 |
DOIs | |
Publication status | Published - 20 May 2017 |
Trastuzumab and paclitaxel in patients (pts) with EGFR mutated non-small-cell lung cancer (NSCLC) that express HER2 after progression on EGFR TKI treatment.
Joop De Langen, Justine Leonie Kuiper, Erik Thunnissen, Sayed M. S. Hashemi, Kim Monkhorst, Egbert F. Smit
Research output: Contribution to journal › Meeting Abstract › Academic